Does TAZOBACTAM Cause Interstitial lung disease? 14 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Interstitial lung disease have been filed in association with TAZOBACTAM. This represents 1.9% of all adverse event reports for TAZOBACTAM.
14
Reports of Interstitial lung disease with TAZOBACTAM
1.9%
of all TAZOBACTAM reports
9
Deaths
3
Hospitalizations
How Dangerous Is Interstitial lung disease From TAZOBACTAM?
Of the 14 reports, 9 (64.3%) resulted in death, 3 (21.4%) required hospitalization, and 1 (7.1%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TAZOBACTAM. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does TAZOBACTAM Cause?
Pyrexia (84)
Drug ineffective (73)
Off label use (54)
Acute kidney injury (53)
Condition aggravated (51)
Platelet count decreased (48)
Neutrophil count increased (47)
Eosinophilia (40)
Chills (39)
Leukopenia (35)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which TAZOBACTAM Alternatives Have Lower Interstitial lung disease Risk?
TAZOBACTAM vs TBO-FILGRASTIM
TAZOBACTAM vs TEBENTAFUSP-TEBN
TAZOBACTAM vs TECFIDERA
TAZOBACTAM vs TECHNETIUM TC-99M
TAZOBACTAM vs TECHNETIUM TC-99M MEDRONATE